The Cannabis ETF (THCX)
ARCA ARCA Primary 
Cannabis Stocks to Watch in 2025: Top Companies and Trading Strategies to Consider
The cannabis sector has faced significant turbulence in 2025, with recent legislative developments in Florida creating a noticeable pullback. Florida voters rejected Amendment 3, which sought to legalize recreational cannabis, causing a ripple effect across the U.S. cannabis market. Despite the setback, the sector still holds immense potential for long-term growth, with experts forecasting a steady rise in revenue and expansion over the next five years. This article explores the current state of the cannabis industry, provides insights into four top U.S. cannabis companies poised for recovery, and discusses effective trading strategies using technical indicators.
Cannabis/Beer Company Tilray Outlines Plan To Reduce Its Beverage Portfolio, Reports Mixed Q2 Earnings
On Friday, Tilray Brands, Inc's. TLRY second-quarter net revenue increased 9% year-over-year to $210.95 million, missing the consensus of $216.91 million.
Best Cannabis REITs Offering Growth and Dividends After Recent Decline
Cannabis-focused real estate investment trusts (REITs) have become a popular way for investors to access the growing cannabis sector. These REITs provide financing to licensed cannabis operators by leasing properties used for cultivation, processing, and retail. Many cannabis REITs offer high dividend yields, making them attractive to income-focused investors. For example, some REITs yield over 8%, significantly higher than traditional REITs. Meanwhile, the U.S. cannabis industry continues to grow rapidly. According to recent reports, the U.S. market is projected to reach $41 billion by 2025. This growth is fueled by increased legalization efforts and expanding consumer demand. Recent headlines about potential federal cannabis reform have reignited investor interest. The evolving legal landscape presents opportunities and challenges, underscoring the importance of research and analysis.
Failed Recreational Vote In Florida Will Not Deter Trulieve Cannabis
Trulieve Cannabis had a lot to gain if Florida had passed recreational cannabis legislation in the last election. Regardless of the outcome, the company is well-positioned for growth in Florida and other cannabis markets in the US, like Ohio. Trulieve recently reported Q3-2024 financial results, which showed improved performance across the board.
Top Marijuana Penny Stocks to Watch for January 2025: High-Risk, High-Reward Opportunities in Cannabis
The US cannabis industry is rapidly expanding, with sales projected to reach $72 billion by 2030, driven by legalization efforts. Recent headlines highlight progress, including discussions on federal reform and states advancing medical and recreational cannabis laws. This growth creates opportunities for marijuana penny stocks, which are often underpriced and highly volatile. These stocks appeal to investors seeking high-reward opportunities in the evolving cannabis market. However, investing in penny stocks requires caution, as their volatility can lead to significant losses without proper risk management.
Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
Innovative Industrial Properties: 8.1% YTM Bonds Offer Best Bet On Cannabis
Innovative Industrial Properties tanked as news of default by its largest tenant hit. The stock now yields 11% and the preferred shares yield over 9%. We look at the safety of these two and also the safest place in the capital stack.
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by 2025, legalization efforts are gaining traction. Recent news highlights growing bipartisan support for federal cannabis reform in the U.S., which could further boost industry expansion. Canadian cannabis companies, with their well-established infrastructure and international presence, are strategically positioned to capitalize on this growth. Tracking key stocks with solid fundamentals and technical setups becomes essential as investors look for potential gains.
As The Cannabis Industry Grows Marijuana Stocks May Rise
Back around 2010 more states began to legalize recreational cannabis. This led to a big outbreak of more people using cannabis within those regions. This also helped with seeing a pivotal change that allowed for the structure of a legal, regulated market. One that particularly and drastically reduced the influence of the illegal cannabis business. By 2023, the legal cannabis sector has blossomed into a multi-billion dollar industry. In 2025 projections indicate a continued expansion as more places consider legalization.
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cannabis LP Motif Labs which will set Organigram in the top spot in Canada by market share. Organigram has increased its international footprint with an investment in Sanity Group in Germany and in Open Book Extracts in the US.
Cannabis REIT Innovative Industrial Properties Is Finally A Buy
IIPR's stock dropped 23% due to a large tenant, PharmaCann, failing to pay $4.2 million in rent, representing 17% of IIPR's rental revenue. Despite some tenant issues, IIPR has grown substantially since its IPO, maintaining a strong balance sheet and increasing revenue, free cash flow, earnings, and dividends. IIPR is now reasonably priced, trading at 1.1X tangible book value with a dividend yield above 10%, making it an attractive buy.
Better Marijuana Stock: Aurora Cannabis or Tilray Brands?
The global cannabis market tells a tale of survival and adaptation. After a brutal multiyear shakeout that saw dozens of companies fold or merge, the remaining players have emerged battle-tested and strategically transformed.
